TSX Gems: 3 Promising Penny Stocks With At Least CA$20M Market Cap

The Canadian equity markets have shown impressive resilience despite recent economic challenges, with a notable shift in investment focus towards larger U.S. technology stocks. Amidst these macroeconomic dynamics, penny stocks—though an old term—remain relevant as they often represent smaller or newer companies that can offer significant growth potential when supported by strong financials. This article explores three promising penny stocks on the TSX that combine robust balance sheets with the potential for substantial returns, offering investors a chance to uncover hidden value in quality companies.

We're going to check out a few of the best picks from our screener tool.

CEMATRIX (TSX:CEMX)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: CEMATRIX Corporation, with a market cap of CA$72.63 million, manufactures and sells cellular concrete products through its subsidiaries in North America, including Canada and the United States.

Operations: The company generates revenue of CA$53.85 million from the supply and placement of cellular concrete across its North American operations.

Market Cap: CA$72.63M

CEMATRIX Corporation, with a market cap of CA$72.63 million, has shown significant earnings growth of 214.2% over the past year, outperforming the Basic Materials industry. The company's financial health is robust, with short-term assets exceeding both short- and long-term liabilities and debts well covered by operating cash flow. Recent contract awards totaling $17 million signal strong future prospects in North America. CEMATRIX's management remains focused on accretive acquisitions to drive growth without diluting shareholder value. Despite trading below estimated fair value, its seasoned board and stable volatility suggest a balanced risk profile for investors interested in penny stocks.

• Click to explore a detailed breakdown of our findings in CEMATRIX's financial health report.
• Gain insights into CEMATRIX's future direction by reviewing our growth report.

East Africa Metals (TSXV:EAM)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: East Africa Metals Inc. is a mineral exploration company engaged in the identification, acquisition, exploration, development, and sale of base and precious mineral resource properties in Ethiopia and Tanzania, with a market cap of CA$21.52 million.

Operations: No revenue segments have been reported for the company.

Market Cap: CA$21.52M

East Africa Metals Inc., with a market cap of CA$21.52 million, remains pre-revenue and faces significant financial challenges. The company reported a substantial net loss of CA$15.72 million for the year ended March 31, 2026, up from CA$2.3 million the previous year, raising concerns about its ability to continue as a going concern according to its auditor's report. Although debt-free and with short-term assets exceeding liabilities by CA$1.5 million, EAM's high volatility and negative return on equity highlight its speculative nature within the penny stock realm in Canada’s mining sector.

• Navigate through the intricacies of East Africa Metals with our comprehensive balance sheet health report here.
• Evaluate East Africa Metals' historical performance by accessing our past performance report.

Mene (TSXV:MENE)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Mene Inc. designs, manufactures, and markets 24 karat gold and platinum jewelry globally, with a market cap of CA$44.33 million.

Operations: The company generates revenue primarily from its Jewelry & Watches segment, totaling CA$29.37 million.

Market Cap: CA$44.33M

Mene Inc., with a market cap of CA$44.33 million, has recently turned profitable, reporting net income of CA$1.66 million for the first half of 2026. The company operates without debt and maintains high-quality earnings, with short-term assets significantly exceeding both short-term and long-term liabilities. Despite its profitability, Mene's share price remains highly volatile over the past three months. Additionally, the company announced a share buyback program to repurchase up to 5% of its issued shares by September 2027, potentially enhancing shareholder value by reducing outstanding shares in the market.

• Click here and access our complete financial health analysis report to understand the dynamics of Mene.
• Review our historical performance report to gain insights into Mene's track record.

Key Takeaways

• Click this link to deep-dive into the 340 companies within our TSX Penny Stocks screener.
• Curious About Other Options? AI is about to change healthcare. These 129 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com